Bank of Montreal
ARCT icon

Bank of Montreal’s Arcturus Therapeutics ARCT Stock Holding History

Bank of Montreal’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,313
Closed -$435K – 3835
2024
Q1 		$435K Buy
+11,313
New +$401K ﹤0.01% 2531
2023
Q4 		– Sell
-12,630
Closed -$373K – 3962
2023
Q3 		$373K Buy
+12,630
New +$389K ﹤0.01% 2648
2021
Q2 		– Sell
-927
Closed -$35K – 3709
2021
Q1 		$35K Sell
927
-16,959
-95% -$1.01M ﹤0.01% 3843
2020
Q4 		$1.25M Buy
17,886
+3,261
+22% +$221K ﹤0.01% 2094
2020
Q3 		$690K Sell
14,625
-1,363
-9% -$67.7K ﹤0.01% 2164
2020
Q2 		$778K Sell
15,988
-44,015
-73% -$1.52M ﹤0.01% 2054
2020
Q1 		$760K Buy
60,003
+4,077
+7% +$52.2K ﹤0.01% 1807
2019
Q4 		$608K Buy
+55,926
New +$585K ﹤0.01% 2560

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Bank of Montreal's ARCT Position: Q2 2024 in Review

Bank of Montreal sold out of Arcturus Therapeutics (ARCT) in Q2 2024, closing a stake of 11,313 shares — an estimated $435K sold.

Bank of Montreal first reported a position in ARCT in Q4 2019 and held it in 8 quarters. The position peaked at $1.25M in Q4 2020. 170 funds tracked by Wall St. Rank hold ARCT as of Q2 2024.

  • Bank of Montreal reported no remaining Arcturus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 11,313 Arcturus Therapeutics shares in Q2 2024, an estimated $435K.
  • Bank of Montreal first reported a position in Arcturus Therapeutics in Q4 2019 and held it in 8 quarters.
  • Bank of Montreal's Arcturus Therapeutics position peaked at $1.25M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.